Indivior (INDV) Q2 2026: EPS Beats by 25%, SUBLOCADE Sets Record
As seen on the 24/7 Wall St. homepage on August 3, 2026.
Indivior torched consensus estimates with a 24.76% EPS beat and raised full-year guidance as SUBLOCADE, its long-acting injectable buprenorphine treatment, posted 21% revenue growth and a record 32,816 new patient starts. The opioid-use-disorder drug is now pulling 76% of the U.S. long-acting buprenorphine market, signaling durable demand and a potential inflection point ahead of the company's pending all-stock merger with Supernus.
Continue ReadingShow less
Indivior reported Q2 2026 earnings per share of $1.15, clearing the consensus estimate of $0.92 by nearly 25%. Revenue came in at $343 million, topping estimates of $307.55 million by about 11.5%. The strong beat prompted management to raise its full-year guidance, continuing a streak of outperformance that stretches back through the last several quarters.
The engine behind the results is SUBLOCADE, Indivior's long-acting injectable buprenorphine for opioid-use disorder. The drug posted 21% revenue growth and recorded a single-quarter high of 32,816 new patient starts, while commanding 76% of the U.S. long-acting buprenorphine market. That level of market share points to deeply entrenched demand and suggests the product still has room to pull in patients who have not yet started treatment.
Disclosure
1 INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA( www.finra.org )/SIPC( www.sipc.org ). 2 The probability of a member receiving $3,000 is 0.028%. If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Members must fund their account with a minimum of $50.00 to qualify. The probability percentage is subject to decrease. Members are only eligible for the Stock Award promotion upon opening their first brokerage account; subsequent cash brokerage accounts are ineligible for the promo, including for members with multiple accounts. 3 Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. 4 There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event.
SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. (Sponsor)
The quarter takes on added significance given Indivior's pending all-stock merger with Supernus. A raised guidance outlook and a flagship product at record volumes strengthen Indivior's negotiating position and could influence how the combined company is valued as the deal moves toward close.
Mentioned: INDV